Hospital and Nursing Home Probiotics Market Report 2026

The hospital and nursing home probiotics market size has grown rapidly in recent years. It will grow from $1.69 billion in 2025 to $1.88 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growing awareness of gut health benefits, rising antibiotic usage leading to digestive complications, increasing elderly population in nursing homes, expansion of clinical nutrition practices, growing availability of probiotic formulations.

The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising focus on microbiome-based health management, increasing demand for immune support solutions, growing incidence of gastrointestinal disorders, expansion of hospital-based preventive care programs, increasing use of probiotics in long-term care facilities. Major trends in the forecast period include increasing use of probiotics in clinical nutrition protocols, growing adoption of probiotics for elderly and immunocompromised care, rising integration of probiotics in preventive healthcare regimens, expansion of condition-specific probiotic formulations, increasing acceptance of probiotics as adjunct therapy in hospitals.

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the hospital and nursing home probiotics market in the coming years. Gastrointestinal disorders encompass a variety of conditions affecting the digestive system, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The growing incidence of these disorders is driven by factors including unhealthy dietary patterns, higher intake of processed foods, sedentary lifestyles, and elevated stress levels. Probiotics used in hospital and nursing home settings support the management of gastrointestinal disorders by restoring healthy gut microbiota balance, enhancing digestive function, and reducing symptoms such as diarrhea, constipation, and bloating. For example, in December 2023, according to the IBD Registry, a UK-based non-profit organization, by 2023 the number of individuals diagnosed with Inflammatory Bowel Disease (IBD) exceeded 5,300, reflecting an increase of more than 3,000 members compared to 2022. Therefore, the rising prevalence of gastrointestinal disorders is contributing to the growth of the hospital and nursing home probiotics market.

Major companies operating in the hospital and nursing home probiotics market are emphasizing the development of innovative products, such as probiotic solutions, to improve patient gut health, enhance recovery outcomes, and mitigate antibiotic-related side effects. Probiotic solutions are products that contain live microorganisms which deliver health benefits when consumed in sufficient quantities, primarily by improving the balance of beneficial bacteria in the digestive tract. For instance, in October 2024, Probi AB, a Sweden-based biotechnology company specializing in probiotics, introduced Metabolic Health by Probi for healthcare environments. Metabolic Health by Probi is a clinically supported probiotic solution designed to promote metabolic health, cardiovascular function, weight management, and blood pressure control by combining two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2).

In June 2023, Clasado Limited, a UK-based biotechnology company, entered into a partnership with Probi AB to advance the development of synbiotic products aimed at improving gut health. The collaboration between Clasado Limited and Probi AB seeks to combine their respective expertise to accelerate the development and commercialization of scientifically validated synbiotic products targeting specific health benefits. Probi AB is a Sweden-based biotechnology company that focuses on the development and commercialization of probiotic-based products supported by scientific research, as well as preclinical and clinical studies.

Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, Abbott Laboratories, Danone S.A., Yakult Honsha Co. Ltd., BioGaia AB, Lactalis Group, General Mills Inc., Arla Foods Group, Glanbia PLC, SymbioPharm GmbH, Klaire Labs, Procter & Gamble Company, Vitakem Nutraceuticals, Synlogic Inc., Bayer AG, Sanofi, Meiji Holdings Co. Ltd., Morinaga Milk Industry Co. Ltd., Otsuka Holdings Co. Ltd., Reckitt Benckiser Group plc.

North America was the largest region in the hospital and nursing home probiotics market in 2025. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hospital and nursing home probiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the hospital and nursing home probiotics market by increasing the cost of imported probiotic strains, fermentation inputs, and specialized packaging materials used in supplement manufacturing. These effects are most pronounced in capsule, powder, and liquid formulation segments and in regions such as North America and Europe that depend on global biotechnology and nutraceutical supply chains. While higher costs may affect pricing and procurement volumes in healthcare facilities, tariffs are also encouraging local production, regional sourcing of strains, and investments in domestic manufacturing capabilities, supporting long-term supply stability.

The hospital and nursing home probiotics market research report is one of a series of new reports that provides hospital and nursing home probiotics market statistics, including hospital and nursing home probiotics industry global market size, regional shares, competitors with a hospital and nursing home probiotics market share, detailed hospital and nursing home probiotics market segments, market trends and opportunities, and any further data you may need to thrive in the hospital and nursing home probiotics industry. This hospital and nursing home probiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hospital and nursing home probiotics are dietary supplements that contain live microorganisms and provide health benefits. They help support digestive health, strengthen immune function, and enhance overall wellbeing. These probiotics are particularly advantageous for vulnerable populations, including elderly individuals and patients with compromised immune systems.

The primary indications for hospital and nursing home probiotics include antibiotic-associated diarrhea, irritable bowel syndrome, Clostridium difficile infection, inflammatory bowel disease, and general gut health. Antibiotic-associated diarrhea refers to diarrhea resulting from antibiotic use, which disrupts the gut microbiota and leads to gastrointestinal issues, and is commonly managed with probiotics in healthcare environments. These probiotics are available in multiple formulation types, including capsules, powders, liquids, soft chews, and probiotic yogurt. They are used among various patient groups, such as infants, adults, elderly individuals, immunocompromised patients, and those with gastrointestinal disorders. Distribution occurs through channels including hospitals, nursing homes, pharmacies, online retail platforms, and healthcare facilities, and they are primarily applied in areas such as gut health, immunity, wellness, and other related uses.

The hospital and nursing home probiotics market includes revenues earned by entities by sales of probiotic-infused wound care products, probiotic-infused foods, and medical-grade probiotics and related services such as probiotic therapy and consultation, infection control and prevention, probiotic supplementation programs, and probiotic administration monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.